SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CardioThoracic Systems (CTSI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Jagow who wrote (123)9/23/1997 11:21:00 PM
From: Norm Franklin   of 207
 
No one out there to shed any light on the 9/17 press release about the Access MV?:

<<Last week, Dr. Richard Ott, Cardiac Surgeon and Associate Professor at
University of California, Irvine, performed the second five-vessel off-pump procedure. Dr. Ott commented, ``With the CTS
ACCESS MV System, we were able to perform a five-vessel coronary artery bypass procedure without cardiopulmonary
bypass (CPB). Use of the CTS system made this procedure safe and easy. Access to the target arteries was both efficient
and effective. With this new instrumentation, off-pump bypass is now a technique that can easily be adopted by most
cardiac surgeons. Avoidance of CPB has obvious advantages in patient safety and recovery.''>>

Norm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext